miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
Autor: | Gabriella Ferrandina, Andrea Sacconi, Giovanni Blandino, Rosanna Sestito, Roberta Cianfrocca, Elisa Semprucci, Laura Rosanò, Anna Bagnato, Valeriana Di Castro, Piera Tocci, Valentina Caprara |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
0301 basic medicine
endocrine system diseases Blotting Western Mice Nude Apoptosis Enzyme-Linked Immunosorbent Assay Biology Real-Time Polymerase Chain Reaction Immunoenzyme Techniques 03 medical and health sciences chemistry.chemical_compound Mice 0302 clinical medicine Cell Movement microRNA Tumor Cells Cultured Animals Humans RNA Messenger Receptor Protein kinase B endothelin A receptor Cell Proliferation Ovarian Neoplasms Cell growth Reverse Transcriptase Polymerase Chain Reaction chemoresistance Receptor Endothelin A Xenograft Model Antitumor Assays Vascular endothelial growth factor ovarian carcinoma MicroRNAs 030104 developmental biology Oncology chemistry Drug Resistance Neoplasm 030220 oncology & carcinogenesis Mitogen-activated protein kinase Immunology endothelin-1 Cancer research biology.protein Ectopic expression Female miR-30a Signal transduction Research Paper |
Zdroj: | Oncotarget ResearcherID |
ISSN: | 1949-2553 |
Popis: | Drug resistance remains the major clinical barrier to successful treatment in epithelial ovarian carcinoma (EOC) patients, and the evidence of microRNA involvement in drug resistance has been recently emerging. Endothelin-1 (ET-1)/ETA receptor (ETAR) axis is aberrantly activated in chemoresistant EOC cells and elicits pleiotropic effects promoting epithelial-to-mesenchymal transition (EMT) and the acquisition of chemoresistance. However, the relationship between ETAR and miRNA is still unknown. Hence, in this study we evaluated whether dysregulation of miRNA might enhance ETAR expression in sensitive and resistant EOC cells. Based on bioinformatic tools, we selected putative miRNA able to recognize the 3'UTR of ETAR. An inverse correlation was observed between the expression levels of miR-30a and ETAR in both EOC cell lines and tumor samples. miR-30a was found to specifically bind to the 3'UTR of ETAR mRNA, indicating that ETAR is a direct target of miR-30a. Overexpression of miR-30a decreased Akt and mitogen activated protein kinase signaling pathway activation, cell proliferation, invasion, plasticity, EMT marker levels, and vascular endothelial growth factor release. Interestingly, ectopic expression of miR-30a re-sensitized platinum-resistant EOC cells to cisplatinum-induced apoptosis. Consistently, resistant EOC xenografts overexpressing miR-30a resulted in significantly less tumor growth than controls. Together our study provides a new perspective on the regulatory mechanism of ETAR gene. Interestingly, our findings highlight that blockade of ETAR regulatory axis is the mechanism underlying the tumor suppressor function of miR-30a in chemoresistant EOC cells. |
Databáze: | OpenAIRE |
Externí odkaz: |